Literature DB >> 17517376

Effect of 15-lipoxygenase metabolites, 15-(S)-HPETE and 15-(S)-HETE on chronic myelogenous leukemia cell line K-562: reactive oxygen species (ROS) mediate caspase-dependent apoptosis.

Suraneni V K Mahipal1, Jagu Subhashini, Madhava C Reddy, Metukuri M Reddy, Kotha Anilkumar, Karnati R Roy, Gorla V Reddy, Pallu Reddanna.   

Abstract

Growth inhibitory effects of 15-lipoxygenase-1 [13-(S)-HPODE and 13-(S)-HODE] and 15-lipoxygenase-2 [15-(S)-HPETE and 15-(S)-HETE] (15-LOX-1 and LOX-2) metabolites and the underlying mechanisms were studied on chronic myeloid leukemia cell line (K-562). The hydroperoxy metabolites, 15-(S)-HPETE and 13-(S)-HPODE rapidly inhibited the growth of K-562 cells by 3h with IC(50) values, 10 and 15microM, respectively. In contrast, the hydroxy metabolite of 15-LOX-2, 15-(S)-HETE, showed 50% inhibition only at 40microM by 6h and 13-(S)-HODE, hydroxy metabolite of 15-LOX-1, showed no significant effect up to 160microM. The cells exposed to 10microM of 15-(S)-HPETE and 40microM of 15-(S)-HETE showed typical apoptotic features like release of cytochrome c, caspase-3 activation and PARP-1 (poly(ADP) ribose polymerase-1) cleavage. A flow cytometry based DCFH-DA analysis and inhibitory studies with DPI, a pharmacological inhibitor of NADPH oxidase, NAC (N-acetyl cysteine) and GSH revealed that NADPH oxidase-mediated generation of ROS is responsible for caspase-3 activation and subsequent induction of apoptosis in the K-562 cell line.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17517376     DOI: 10.1016/j.bcp.2007.04.005

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  24 in total

Review 1.  Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species.

Authors:  Kyung-Jin Cho; Ji-Min Seo; Jae-Hong Kim
Journal:  Mol Cells       Date:  2011-03-18       Impact factor: 5.034

Review 2.  Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1.

Authors:  Melis Çolakoğlu; Sinem Tunçer; Sreeparna Banerjee
Journal:  Cell Prolif       Date:  2018-07-30       Impact factor: 6.831

3.  Hematopoietic stem cell function requires 12/15-lipoxygenase-dependent fatty acid metabolism.

Authors:  Michelle Kinder; Cong Wei; Suresh G Shelat; Mondira Kundu; Liang Zhao; Ian A Blair; Ellen Puré
Journal:  Blood       Date:  2010-03-31       Impact factor: 22.113

Review 4.  Role of ROS and RNS Sources in Physiological and Pathological Conditions.

Authors:  Sergio Di Meo; Tanea T Reed; Paola Venditti; Victor Manuel Victor
Journal:  Oxid Med Cell Longev       Date:  2016-07-12       Impact factor: 6.543

5.  Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis.

Authors:  Venkat Vangaveti; Bernhard T Baune; R Lee Kennedy
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

6.  Effect of 15-lipoxygenase metabolites on angiogenesis: 15(S)-HPETE is angiostatic and 15(S)-HETE is angiogenic.

Authors:  Sasikumar J Soumya; Sheela Binu; A Helen; K Anil Kumar; P Reddanna; Perumana R Sudhakaran
Journal:  Inflamm Res       Date:  2012-03-27       Impact factor: 4.575

Review 7.  Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxia-induced pulmonary hypertension.

Authors:  Daling Zhu; Yajuan Ran
Journal:  J Physiol Sci       Date:  2012-02-14       Impact factor: 2.781

8.  Oleic acid promotes adaptability against oxidative stress in 3T3-L1 cells through lipohormesis.

Authors:  Haruna Haeiwa; Takashi Fujita; Yasukazu Saitoh; Nobuhiko Miwa
Journal:  Mol Cell Biochem       Date:  2014-01       Impact factor: 3.396

9.  Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence.

Authors:  M V Suraneni; R Schneider-Broussard; J R Moore; T C Davis; C J Maldonado; H Li; R A Newman; D Kusewitt; J Hu; P Yang; D G Tang
Journal:  Oncogene       Date:  2010-05-31       Impact factor: 9.867

10.  Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival.

Authors:  Yaoyu Chen; Cong Peng; Sheela A Abraham; Yi Shan; Zhiru Guo; Ngoc Desouza; Giulia Cheloni; Dongguang Li; Tessa L Holyoake; Shaoguang Li
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.